Integrative systems biology reveals NKG2A-biased immune responses correlate with protection in infectious disease, autoimmune disease, and cancer

Summary: Infection, autoimmunity, and cancer are principal human health challenges of the 21st century. Often regarded as distinct ends of the immunological spectrum, recent studies hint at potential overlap between these diseases. For example, inflammation can be pathogenic in infection and autoimm...

Full description

Bibliographic Details
Main Authors: Daniel G. Chen, Jingyi Xie, Jongchan Choi, Rachel H. Ng, Rongyu Zhang, Sarah Li, Rick Edmark, Hong Zheng, Ben Solomon, Katie M. Campbell, Egmidio Medina, Antoni Ribas, Purvesh Khatri, Lewis L. Lanier, Philip J. Mease, Jason D. Goldman, Yapeng Su, James R. Heath
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Cell Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2211124724002006
_version_ 1797287635200245760
author Daniel G. Chen
Jingyi Xie
Jongchan Choi
Rachel H. Ng
Rongyu Zhang
Sarah Li
Rick Edmark
Hong Zheng
Ben Solomon
Katie M. Campbell
Egmidio Medina
Antoni Ribas
Purvesh Khatri
Lewis L. Lanier
Philip J. Mease
Jason D. Goldman
Yapeng Su
James R. Heath
author_facet Daniel G. Chen
Jingyi Xie
Jongchan Choi
Rachel H. Ng
Rongyu Zhang
Sarah Li
Rick Edmark
Hong Zheng
Ben Solomon
Katie M. Campbell
Egmidio Medina
Antoni Ribas
Purvesh Khatri
Lewis L. Lanier
Philip J. Mease
Jason D. Goldman
Yapeng Su
James R. Heath
author_sort Daniel G. Chen
collection DOAJ
description Summary: Infection, autoimmunity, and cancer are principal human health challenges of the 21st century. Often regarded as distinct ends of the immunological spectrum, recent studies hint at potential overlap between these diseases. For example, inflammation can be pathogenic in infection and autoimmunity. T resident memory (TRM) cells can be beneficial in infection and cancer. However, these findings are limited by size and scope; exact immunological factors shared across diseases remain elusive. Here, we integrate large-scale deeply clinically and biologically phenotyped human cohorts of 526 patients with infection, 162 with lupus, and 11,180 with cancer. We identify an NKG2A+ immune bias as associative with protection against disease severity, mortality, and autoimmune/post-acute chronic disease. We reveal that NKG2A+ CD8+ T cells correlate with reduced inflammation and increased humoral immunity and that they resemble TRM cells. Our results suggest NKG2A+ biases as a cross-disease factor of protection, supporting suggestions of immunological overlap between infection, autoimmunity, and cancer.
first_indexed 2024-03-07T18:36:12Z
format Article
id doaj.art-66da9e46dc354e898aea61faa116e5ae
institution Directory Open Access Journal
issn 2211-1247
language English
last_indexed 2024-03-07T18:36:12Z
publishDate 2024-03-01
publisher Elsevier
record_format Article
series Cell Reports
spelling doaj.art-66da9e46dc354e898aea61faa116e5ae2024-03-02T04:53:59ZengElsevierCell Reports2211-12472024-03-01433113872Integrative systems biology reveals NKG2A-biased immune responses correlate with protection in infectious disease, autoimmune disease, and cancerDaniel G. Chen0Jingyi Xie1Jongchan Choi2Rachel H. Ng3Rongyu Zhang4Sarah Li5Rick Edmark6Hong Zheng7Ben Solomon8Katie M. Campbell9Egmidio Medina10Antoni Ribas11Purvesh Khatri12Lewis L. Lanier13Philip J. Mease14Jason D. Goldman15Yapeng Su16James R. Heath17Institute of Systems Biology, Seattle, WA, USA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Clinical Research Division, Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA, USAInstitute of Systems Biology, Seattle, WA, USA; Molecular Engineering & Sciences Institute, University of Washington, Seattle, WA, USAInstitute of Systems Biology, Seattle, WA, USAInstitute of Systems Biology, Seattle, WA, USA; Department of Bioengineering, University of Washington, Seattle, WA, USAInstitute of Systems Biology, Seattle, WA, USA; Department of Bioengineering, University of Washington, Seattle, WA, USAInstitute of Systems Biology, Seattle, WA, USAInstitute of Systems Biology, Seattle, WA, USAInstitute for Immunity, Transplantation and Infection, School of Medicine, Stanford University, Stanford, CA, USA; Center for Biomedical Informatics Research, Department of Medicine, School of Medicine, Stanford University, Stanford, CA, USADepartment of Pediatrics, Division of Allergy and Immunology, Stanford School of Medicine, Stanford, CA, USADepartment of Medicine, Division of Hematology–Oncology, University of California, Los Angeles, Los Angeles, CA, USA; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USADepartment of Medicine, Division of Hematology–Oncology, University of California, Los Angeles, Los Angeles, CA, USADepartment of Medicine, Division of Hematology–Oncology, University of California, Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, CA, USA; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USAInstitute for Immunity, Transplantation and Infection, School of Medicine, Stanford University, Stanford, CA, USA; Center for Biomedical Informatics Research, Department of Medicine, School of Medicine, Stanford University, Stanford, CA, USADepartment of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, USA; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USASwedish Center for Research and Innovation, Swedish Medical Center, Seattle, WA, USA; Providence St. Joseph Health, Renton, WA, USASwedish Center for Research and Innovation, Swedish Medical Center, Seattle, WA, USA; Providence St. Joseph Health, Renton, WA, USA; Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USAVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Clinical Research Division, Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA, USAInstitute of Systems Biology, Seattle, WA, USA; Department of Bioengineering, University of Washington, Seattle, WA, USA; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA; Corresponding authorSummary: Infection, autoimmunity, and cancer are principal human health challenges of the 21st century. Often regarded as distinct ends of the immunological spectrum, recent studies hint at potential overlap between these diseases. For example, inflammation can be pathogenic in infection and autoimmunity. T resident memory (TRM) cells can be beneficial in infection and cancer. However, these findings are limited by size and scope; exact immunological factors shared across diseases remain elusive. Here, we integrate large-scale deeply clinically and biologically phenotyped human cohorts of 526 patients with infection, 162 with lupus, and 11,180 with cancer. We identify an NKG2A+ immune bias as associative with protection against disease severity, mortality, and autoimmune/post-acute chronic disease. We reveal that NKG2A+ CD8+ T cells correlate with reduced inflammation and increased humoral immunity and that they resemble TRM cells. Our results suggest NKG2A+ biases as a cross-disease factor of protection, supporting suggestions of immunological overlap between infection, autoimmunity, and cancer.http://www.sciencedirect.com/science/article/pii/S2211124724002006CP: Immunology
spellingShingle Daniel G. Chen
Jingyi Xie
Jongchan Choi
Rachel H. Ng
Rongyu Zhang
Sarah Li
Rick Edmark
Hong Zheng
Ben Solomon
Katie M. Campbell
Egmidio Medina
Antoni Ribas
Purvesh Khatri
Lewis L. Lanier
Philip J. Mease
Jason D. Goldman
Yapeng Su
James R. Heath
Integrative systems biology reveals NKG2A-biased immune responses correlate with protection in infectious disease, autoimmune disease, and cancer
Cell Reports
CP: Immunology
title Integrative systems biology reveals NKG2A-biased immune responses correlate with protection in infectious disease, autoimmune disease, and cancer
title_full Integrative systems biology reveals NKG2A-biased immune responses correlate with protection in infectious disease, autoimmune disease, and cancer
title_fullStr Integrative systems biology reveals NKG2A-biased immune responses correlate with protection in infectious disease, autoimmune disease, and cancer
title_full_unstemmed Integrative systems biology reveals NKG2A-biased immune responses correlate with protection in infectious disease, autoimmune disease, and cancer
title_short Integrative systems biology reveals NKG2A-biased immune responses correlate with protection in infectious disease, autoimmune disease, and cancer
title_sort integrative systems biology reveals nkg2a biased immune responses correlate with protection in infectious disease autoimmune disease and cancer
topic CP: Immunology
url http://www.sciencedirect.com/science/article/pii/S2211124724002006
work_keys_str_mv AT danielgchen integrativesystemsbiologyrevealsnkg2abiasedimmuneresponsescorrelatewithprotectionininfectiousdiseaseautoimmunediseaseandcancer
AT jingyixie integrativesystemsbiologyrevealsnkg2abiasedimmuneresponsescorrelatewithprotectionininfectiousdiseaseautoimmunediseaseandcancer
AT jongchanchoi integrativesystemsbiologyrevealsnkg2abiasedimmuneresponsescorrelatewithprotectionininfectiousdiseaseautoimmunediseaseandcancer
AT rachelhng integrativesystemsbiologyrevealsnkg2abiasedimmuneresponsescorrelatewithprotectionininfectiousdiseaseautoimmunediseaseandcancer
AT rongyuzhang integrativesystemsbiologyrevealsnkg2abiasedimmuneresponsescorrelatewithprotectionininfectiousdiseaseautoimmunediseaseandcancer
AT sarahli integrativesystemsbiologyrevealsnkg2abiasedimmuneresponsescorrelatewithprotectionininfectiousdiseaseautoimmunediseaseandcancer
AT rickedmark integrativesystemsbiologyrevealsnkg2abiasedimmuneresponsescorrelatewithprotectionininfectiousdiseaseautoimmunediseaseandcancer
AT hongzheng integrativesystemsbiologyrevealsnkg2abiasedimmuneresponsescorrelatewithprotectionininfectiousdiseaseautoimmunediseaseandcancer
AT bensolomon integrativesystemsbiologyrevealsnkg2abiasedimmuneresponsescorrelatewithprotectionininfectiousdiseaseautoimmunediseaseandcancer
AT katiemcampbell integrativesystemsbiologyrevealsnkg2abiasedimmuneresponsescorrelatewithprotectionininfectiousdiseaseautoimmunediseaseandcancer
AT egmidiomedina integrativesystemsbiologyrevealsnkg2abiasedimmuneresponsescorrelatewithprotectionininfectiousdiseaseautoimmunediseaseandcancer
AT antoniribas integrativesystemsbiologyrevealsnkg2abiasedimmuneresponsescorrelatewithprotectionininfectiousdiseaseautoimmunediseaseandcancer
AT purveshkhatri integrativesystemsbiologyrevealsnkg2abiasedimmuneresponsescorrelatewithprotectionininfectiousdiseaseautoimmunediseaseandcancer
AT lewisllanier integrativesystemsbiologyrevealsnkg2abiasedimmuneresponsescorrelatewithprotectionininfectiousdiseaseautoimmunediseaseandcancer
AT philipjmease integrativesystemsbiologyrevealsnkg2abiasedimmuneresponsescorrelatewithprotectionininfectiousdiseaseautoimmunediseaseandcancer
AT jasondgoldman integrativesystemsbiologyrevealsnkg2abiasedimmuneresponsescorrelatewithprotectionininfectiousdiseaseautoimmunediseaseandcancer
AT yapengsu integrativesystemsbiologyrevealsnkg2abiasedimmuneresponsescorrelatewithprotectionininfectiousdiseaseautoimmunediseaseandcancer
AT jamesrheath integrativesystemsbiologyrevealsnkg2abiasedimmuneresponsescorrelatewithprotectionininfectiousdiseaseautoimmunediseaseandcancer